ATE142496T1 - Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes - Google Patents

Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes

Info

Publication number
ATE142496T1
ATE142496T1 AT89870206T AT89870206T ATE142496T1 AT E142496 T1 ATE142496 T1 AT E142496T1 AT 89870206 T AT89870206 T AT 89870206T AT 89870206 T AT89870206 T AT 89870206T AT E142496 T1 ATE142496 T1 AT E142496T1
Authority
AT
Austria
Prior art keywords
deoxynojirimycin
butyl
treat herpes
herpes
treat
Prior art date
Application number
AT89870206T
Other languages
English (en)
Inventor
Gary Steven Jacob
Thomas William Rademacher
Albert Stanley Tyms
Raymond Allen Dwek
Original Assignee
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Co filed Critical Monsanto Co
Application granted granted Critical
Publication of ATE142496T1 publication Critical patent/ATE142496T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT89870206T 1988-12-22 1989-12-21 Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes ATE142496T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/288,528 US4957926A (en) 1988-12-22 1988-12-22 Method of treating herpesviruses

Publications (1)

Publication Number Publication Date
ATE142496T1 true ATE142496T1 (de) 1996-09-15

Family

ID=23107522

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89870206T ATE142496T1 (de) 1988-12-22 1989-12-21 Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes

Country Status (8)

Country Link
US (1) US4957926A (de)
EP (1) EP0378984B1 (de)
JP (1) JP2831068B2 (de)
AT (1) ATE142496T1 (de)
CA (1) CA2006267C (de)
DE (1) DE68927160T2 (de)
ES (1) ES2091766T3 (de)
GR (1) GR3021845T3 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252587A (en) * 1990-04-27 1993-10-12 Merrell Dow Pharmaceuticals, Inc. N-derivatives of 1-deoxy nojirimycin
US5536732A (en) * 1990-04-27 1996-07-16 Merrell Pharmaceuticals Inc. N-derivatives of 1-deoxy nojirimycin
US5258518A (en) * 1992-04-01 1993-11-02 G. D. Searle & Co. 2-substituted tertiary carbinol derivatives of deoxynojirimycin
US5331096A (en) * 1992-04-01 1994-07-19 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5268482A (en) * 1992-04-01 1993-12-07 G. D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
US5206251A (en) * 1992-04-01 1993-04-27 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5216168A (en) * 1992-04-01 1993-06-01 G. D. Searle & Co. 2- and 3- amino and azido derivatives of 1,5-iminosugars
US5342951A (en) * 1992-04-01 1994-08-30 G.D. Searle & Co. 2- and 3-sulfur derivatives of 1,5-iminosugars
DK0739205T3 (da) * 1994-01-13 2000-05-01 Searle & Co Anvendelse af N-alkylderivater af 1,5-didesoxy-1,5-imino-D-glucitol til behandling af hepatitis-B-virusinfektioner
AU1876095A (en) * 1994-02-25 1995-09-11 G.D. Searle & Co. Use of 1-deoxynojirimycin and its derivatives for treating mammals infected with respiratory syncytial virus
US20030100532A1 (en) * 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
WO1999024401A1 (en) 1997-11-10 1999-05-20 G.D. Searle & Co. Use of alkylated iminosugars to treat multidrug resistance
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
ATE331515T1 (de) 1998-02-12 2006-07-15 Searle Llc Verwendung von n-substituirten-1,5-dideoxy-1,5- imino-d-glucitolen zur behandlung von hepatitis infektionen
WO2001008672A2 (en) 1999-02-12 2001-02-08 G.D. Searle & Co. Glucamine compounds for treating hepatitis virus infections
ATE402701T1 (de) * 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
WO2001060366A1 (en) * 2000-02-14 2001-08-23 Pharmacia Corporation Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds for treating hepatitis virus infections
AU2001247848A1 (en) 2000-03-31 2001-10-15 Michigan State University Process for the preparation of 1,5-dideoxy-1,5-imino hexitols from oximes or imines
US7973157B2 (en) 2005-06-08 2011-07-05 Amicus Therapeutics, Inc. Imino and amino sugar purification
US8097728B2 (en) * 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
IT201700078102A1 (it) 2017-07-11 2019-01-11 Dipharma Francis Srl Sintesi di un azazucchero e suoi intermedi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
NO154918C (no) * 1977-08-27 1987-01-14 Bayer Ag Analogifremgangsmaate til fremstilling av terapeutisk aktive derivater av 3,4,5-trihydroksypiperidin.
EP0252962B1 (de) * 1985-12-23 1995-08-23 Fred Hutchinson Cancer Research Center Regulierung der retroviralen replikation, infektion und pathogenese

Also Published As

Publication number Publication date
ES2091766T3 (es) 1996-11-16
EP0378984A3 (de) 1992-07-08
EP0378984A2 (de) 1990-07-25
JPH02212430A (ja) 1990-08-23
GR3021845T3 (en) 1997-02-28
CA2006267C (en) 2000-05-02
DE68927160T2 (de) 1997-03-20
CA2006267A1 (en) 1990-06-22
EP0378984B1 (de) 1996-09-11
JP2831068B2 (ja) 1998-12-02
US4957926A (en) 1990-09-18
DE68927160D1 (de) 1996-10-17

Similar Documents

Publication Publication Date Title
ATE142496T1 (de) Verwendung von n-butyl-deoxynojirimycin zur behandlung von herpes
MY103352A (en) Piperazinyl-heterocyclic compounds
ATE83659T1 (de) Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus.
DE69331605D1 (de) Verwendung von phenserin zur herstellung von medikamenten zur behandlung von kognitiven störungen
DE68923151D1 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
NO172340C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv 1,5-dideoxy-1,5-imino-(n-omega-methyl-caproat)-l-fucitol
GR3025518T3 (en) Use of the N-n-butyl derivative of desoxynojirimycin in the manufacture of a medicament inhibiting HIV-Virus
DE69431199T2 (de) Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ES2081834T3 (es) Pirrolidin-2-onas 4-metil y 4-etil sustituidas.
NO893256D0 (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
DE68918240D1 (de) 1,4-Dihydropyridin-Derivate.
ATE78160T1 (de) Verwendung von ''naftidrofuryl'' zur behandlung von neuropathien.

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee